MULTIPLE MYELOMA
Oral Presentation Room-1
Scientific Chair: Fahir Özkalemkaş (Uludağ Univesity, Bursa), Mutlu Arat (Florence Nightingale Hospital, Turkey)
TITLE PERESENTER NAME
FREE LIGHT CHAIN ESCAPE IN MULTIPLE MYELOMA: IS IT AN EARLY CLUE OF AGGRESSIVE PROGRESSION? BORAN YAVUZ
COMPARISON OF CANCER AND AGING RESEARCH GROUP SCORE (CARG) AND COMORBIDITY INDEX SCORES IN MULTIPLE MYELOMA PATIENTS MEHMET BAYSAL
POSTINDUCTION FDG-PET IMAGING IMPROVES THE IMPACT OF BIOCHEMICAL RESPONSE ASSESSMENT ON TRANSPLANT OUTCOME GÜLDANE CENGİZ SEVAL
PATIENT RELATED FACTORS OVERRIDE LENALIDOMIDE MAINTENANCE AS A FACTOR OF SEVERITY FOR COVID-19 INFECTION EKİN KIRCALI
PACE-LIKE REGIMENS IN THE TREATMENT OF RELAPSED/ REFRACTORY MULTIPLE MYELOMA AYLİN FATMA KARATAŞ
THE IMPACT OF PRETRANSPLANT IMMUNOMODULATORY DRUGS ON CMV REACTIVATION ATİLLA USLU
PRECLINIC/GENETIC
Oral Presentation Room-2
Scientific Chair: Muhlis Cem Ar (İstanbul University -Cerrahpaşa, Turkey), Alphan Küpesiz (Akdeniz University, Turkey)
MYD88 EXPRESSION IN PRIMARY AND SECONDARY CNS LYMPHOMAS BERRİN BALIK AYDIN
PHENOTYPES OF BONE MARROW MONOCYTES IN STEM CELL TRANSPLANTATION FOR ACUTE LEUKEMIA: A DESCRIPTIVE PILOT STUDY EKİN KIRCALI
THE IGLV3-21 LIGHT CHAIN ANALYSIS IN IR-RELATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS NADİİA BİLOUS
KILLER IMMUNOGLOBULIN LIKE HAPLOTYPE BB IS OBSERVED MORE FREQUENTLY AMONG MYELOMA CASES COMPARED TO HEALTHY CONTROLS YALIM AKIN
MUTATION PROFILE OF THE PATIENTS TESTED WITH NEXT GENERATION SEQUENCING AND CLINICAL IMPLICATIONS YAŞA GÜL MUTLU
INFECTION/QUALITY OF LIFE
Oral Presentation Room-3
Scientific Chair: Adalet Meral Güneş (Uludağ University, Turkey), Mustafa Nuri Yenerel (İstanbul University, Turkey)
DETERMINATION OF INFECTION FREQUENCY IN PATIENTS USING RUXOLITINIB DUE TO GRAFT VERSUS HOST DISEASE HÜLYA YILMAZ
EFFICACY OF ANTI-IL-6 ANTIBODY IN THREE PATIENTS WITH COVID-19 INFECTION AND MULTIPLE MYELOMA ANICA DIVAC
ASSESSMENT OF POSSIBLE RISK FACTORS FOR THE DEVELOPMENT OF CORONAVIRUS INFECTION IN PATIENTS WITH HEMATOLOGICAL CANCERS INNA KAMAEVA
OUR CENTER EXPERIENCE OF MULTIPLE MYELOMA PATIENTS WITH COVID-19 MEHMET SEZGİN PEPELER
EVALUATION OF POSSIBLE EFFECTS OF THE COVID-19 PANDEMIC ON FEBRILE NEUTROPENIA EPISODES IN CHILDREN WITH ACUTE LEUKEMIA ŞEBNEM YILMAZ
QUALITY OF LIFE MEASURES OF THE PATIENTS WHO ARE DIAGNOSED WITH HEMATOLOGICAL MALIGNANCIES AND TIME EFFECT ON PARAMETERS BERRİN BALIK AYDIN

LEUKEMIA/LYMPHOMA
Oral Presentation Room-4
Scientific Chair: Düzgün Özatlı (Ondokuz Mayıs University, Turkey), Şebnem Yılmaz (Dokuz Eylül University, Turkey)
EVALUATION OF CLINICAL AND LABORATORY FINDINGS AT DIAGNOSIS AND RELAPSE IN CHILDREN WITH ACUTE LEUKEMIA ŞEBNEM YILMAZ
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS WITH BINUCLEATED LYMPHOCYTES (PPBL) BERRİN BALIK AYDIN
ANALYSIS OF FACTORS PREDICTING EFFICACY OF IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS MESUT TIĞLIOĞLU
DIAGNOSTIC CHALLENGES AND CONSEQUENT THERAPEUTIC DILEMMAS ENCOUNTERED IN CLASSIFYING ACUTE MYELOID LEUKEMIAS MÜRÜVVET SEDA AYDIN
CLINICAL OUTCOMES AND TREATMENT PATTERNS OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA:MULTICENTER RETROSPECTIVE ANALYSIS SERKAN GÜVEN
GIANT MASS IN THE EYELID: T CELL LYMPHOMA FERDA CAN
LYMPHOMA
Oral Presentation Room-5
Scientific Chair: Şule Mine Bakanay Öztürk (Ankara Yıldırım Beyazıt University, Turkey), Ebru Koca (Başkent University, Turkey)
IS SURGICAL EXCISIONAL BIOPSY STILL THE GOLD STANDARD DIAGNOSTIC APPROACH IN LYMPHOMAS? YAŞA GÜL MUTLU
BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTO-SCT IN HIGH-RISK HODGKIN’S LYMPHOMA: MULTI-CENTER RETROSPECTIVE STUDY OLGA MELTEM AKAY
EVALUATION OF PD-1/ PD-L1 EXPRESSION, TUMOR MICROENVIRONMENT AND PROGNOSTIC FACTORS IN DIFFUSE LARGE B CELL LYMPHOMA GÜLDİDAR BASMACI
BROWN ADIPOSE TISSUE FORMATION DUE TO NIVOLUMAB TREATMENT ELÇİN ERDOĞAN YÜCEL
PRIMARY GASTRIC NK/T CELL LYMPHOMA WITH T CELL PHENOTYPE: A RARE EBV RELATED LOCALLY INVOLVED AGRESSIVE LYMPHOMA CASE. DERYA KOYUN
THE EFFECT OF THE CELL OF ORIGIN USING HANS ALGORITHM ON PROGNOSIS IN DIFFUSE LARGE B CELL LYMPHOMAS TAHA ULUTAN KARS